Papillary conjunctivitis is an inflammatory reaction on the underside of the eyelid, where small mound-like bumps called papillae form on the conjunctiva, the thin tissue lining the inner surface of the lid. It is most commonly triggered by contact lens wear but also shows up in several forms of allergic eye disease and in response to other foreign materials resting against the eye. The condition ranges from a mild nuisance that clears up on its own once the irritant is removed to a severe, sight-threatening problem when giant papillae develop alongside corneal ulcers.
What Papillae Actually Are
The conjunctiva that lines the inner eyelid is normally smooth, with a faintly bumpy texture visible only under magnification. When it becomes chronically irritated, the tissue reorganizes into raised mounds, each one built around a central core of tiny blood vessels surrounded by fibrous tissue. Studies of these papillae under the microscope show dense inflammatory cell infiltration around blood vessels, thickened collagen fibers beneath the surface layer, and pockets of mucus-producing goblet cells tucked into folds of the overgrown tissue.
The papillae are graded by size. In clinical practice, anything up to about 0.3 mm across is considered a “fine” papilla and is often a normal finding or a sign of very mild irritation. Papillae between roughly 0.3 and 1.0 mm are called “macro” papillae and usually indicate a meaningful inflammatory response. Once the bumps exceed about 1.0 mm in diameter, clinicians call them “giant” papillae, and the condition earns its more dramatic name: giant papillary conjunctivitis, or GPC. Fluorescein staining can map out the pattern and area of these features across the tarsal plate, with staging systems running from stage 1 through stage 4 based on the size and distribution of the hypertrophy.
Why It Happens
The leading explanation for papillary conjunctivitis, particularly the giant papillary form associated with contact lenses, involves two forces working together: mechanical friction and an immune response to protein deposits. Every time you blink, the upper eyelid slides over whatever is sitting on the eye’s surface. A contact lens creates repetitive micro-trauma against the tarsal conjunctiva. Over time, this physical rubbing irritates and damages the tissue. But mechanical abrasion alone does not fully explain the condition, because the immune system also gets involved. Proteins from tears, especially albumin, adhere to the lens surface and become denatured, meaning their shape changes enough that the body starts treating them as foreign. This combination of chronic physical irritation and an immunologic reaction to those surface deposits is thought to drive the papillary response.
Research has confirmed that contact lenses with higher levels of albumin deposits on their surface are associated with papillary conjunctivitis, supporting the idea that these protein buildups act as an immune trigger on top of the mechanical component.
Contact Lenses as the Most Common Trigger
Contact lens wear is by far the most frequent cause. In a large survey of contact lens complications in Singapore, allergic conjunctivitis accounted for nearly one in five cases, and giant papillary conjunctivitis alone made up about 15% of all complications seen.
How often you replace your lenses matters enormously. A retrospective study of frequent-replacement contact lens wearers found that roughly one in five developed GPC overall, but the rate varied dramatically by replacement schedule. Among those who replaced lenses every four weeks or longer, the incidence hit 36%. Among those replacing more frequently, it dropped to under 5%.
The type of lens also plays a role. Rigid gas-permeable lenses tend to produce fewer complications on average than soft lenses, though papillae and GPC remain the most common complication for both groups. Silicone-based soft lenses showed a slightly lower complication rate than non-silicone soft lenses in one study, although the difference was not statistically significant. Extended wear, where lenses stay in overnight, trended toward a higher complication rate compared with daily wear, though again, the difference in that particular study did not reach statistical significance.
Several additional risk factors have been identified. People with a history of allergies or atopy are significantly more likely to develop GPC. Infrequent lens replacement, long daily wearing times, and inadequate lens hygiene all raise the risk.
Beyond Contact Lenses
Papillary conjunctivitis does not require a contact lens. Any foreign material resting against the conjunctiva for an extended period can trigger the same response. Exposed sutures from eye surgery are a well-documented cause. In one reported case, a fine prolene suture used to close a cataract incision broke through the surface months after surgery, producing a unilateral GPC response on the affected eye. Once the retained suture fragments were removed, the reaction resolved. Biopsy of the tissue showed it looked essentially identical to the papillary response seen in contact lens GPC or in allergic forms of conjunctivitis.
Prosthetic eyes (ocular prostheses) and scleral buckles used in retinal surgery can provoke the same papillary reaction through similar mechanisms: chronic mechanical contact plus an immune response to deposits or degraded surface material. The clinical picture in these cases can look indistinguishable from contact lens-induced GPC, and the management approach follows similar principles of reducing irritation and controlling inflammation.
Papillary Conjunctivitis in Allergic Eye Disease
The papillary response is also a hallmark of several allergic conditions that have nothing to do with contact lenses or foreign bodies. These represent a spectrum of severity, and papillae are a shared clinical feature across the group.
Vernal keratoconjunctivitis (VKC) is one of the most aggressive forms. It predominantly affects children and young adults in warm, dry climates. The defining signs of VKC include cobblestone-like giant papillae on the upper tarsal plate, Trantas dots (small white clumps of inflammatory cells at the edge of the cornea), and shield ulcers on the corneal surface. The giant papillae in VKC can be impressively large and are packed with eosinophils and other inflammatory cells. Histological examination of VKC tissue reveals a chaotic landscape: the mucosa becomes hyperplastic with irregular epithelial ingrowths, dense fibrosis develops beneath the surface, and blood vessels become surrounded by massive inflammatory infiltrates.
Atopic keratoconjunctivitis (AKC) is a chronic condition associated with atopic dermatitis (eczema). Unlike VKC, which tends to favor the upper tarsal conjunctiva, AKC often produces papillary hypertrophy more prominently on the lower tarsal conjunctiva. The signs can include conjunctival redness, tissue thickening, and in advanced cases, scarring and concretions (small calcified deposits within the tissue). AKC tends to be a lifelong condition that waxes and wanes, and the papillary component is one of several features used to assess its severity.
Seasonal allergic conjunctivitis (SAC), the garden-variety hay fever eye, can also produce mild papillae, though these are usually fine and diffuse rather than giant. SAC is far more common than VKC or AKC but far less destructive.
What It Feels Like
The symptoms of papillary conjunctivitis track with severity. In the mildest forms, you might notice slightly increased mucus in the corners of your eyes in the morning or a vague sense that your contact lenses are not as comfortable as they used to be. GPC in particular is characterized by excessive mucus production, itching, blurry vision, and diminished contact lens tolerance. The blurriness often comes from mucus coating the lens or from the swollen papillae physically nudging the lens out of position with each blink.
As the condition progresses, itching becomes more prominent. The eyes may feel gritty or foreign-body-like, and you may find yourself rubbing them frequently, which only worsens the inflammation. In severe allergic forms like VKC, the itching can be intense enough to disrupt sleep and daily activities.
Corneal Complications
The most worrying consequence of severe papillary conjunctivitis is damage to the cornea. Giant papillae on the upper lid act like sandpaper against the corneal surface with each blink, and this can lead to superficial punctate erosions, where tiny areas of the corneal surface are abraded away. In VKC and severe GPC, this process can progress to a shield ulcer, a distinctive oval or shield-shaped erosion on the upper part of the cornea directly beneath the area of worst papillary disease.
Shield ulcers are painful, vision-threatening, and frustratingly stubborn. One clinical report described a patient with recurrent GPC and shield ulcers that persisted despite intensive topical and oral medications, ultimately requiring cryotherapy (freezing treatment applied to the giant papillae) to break the cycle.
The Inflammatory Signature
The immune activity behind papillary conjunctivitis is not a simple allergic reaction. Tear analysis in patients with the more severe allergic forms (VKC and AKC) reveals a complex cocktail of inflammatory signals. Concentrations of pro-inflammatory molecules like IL-1β, IL-6, and TNF-α, along with allergy-associated molecules like IL-13 and IL-5, are significantly elevated compared with healthy eyes. But the picture extends beyond the expected allergy pathway: molecules associated with other arms of the immune system, including IFN-γ and IL-17, are also elevated in VKC and AKC patients but not in milder seasonal allergy.
This mixed inflammatory profile helps explain why severe papillary conjunctivitis can be so difficult to treat. It is not purely an allergy problem that responds neatly to antihistamines. The involvement of multiple immune pathways means that treatment often needs to target inflammation more broadly.
Treatment Approaches
For contact lens-related papillary conjunctivitis, the first step is straightforward: stop wearing the lenses. In mild cases, this alone is enough to resolve both symptoms and signs. When you eventually return to lens wear, the usual recommendation is to switch to more frequently replaced lenses (ideally daily disposables), improve cleaning routines, and reduce daily wearing time.
When lens cessation alone is not enough, or when the cause is not a removable foreign body, medications enter the picture. Topical mast cell stabilizers and antihistamine drops are often the first-line pharmacological options for mild to moderate cases. For more stubborn disease, corticosteroid eye drops can be highly effective. A controlled trial of loteprednol etabonate, a steroid designed to have fewer side effects in the eye, showed that about 78% of treated patients had at least a one-grade improvement in their papillae, compared with 51% receiving placebo. Itching improved in 95% of the loteprednol group versus 81% on placebo.
Steroids, however, carry risks with prolonged use, including elevated eye pressure and cataract formation, so they are typically used in short courses. For chronic allergic forms like VKC and AKC, immunomodulatory agents such as cyclosporine or tacrolimus eye drops offer a steroid-sparing alternative for long-term control. These work by dampening the immune response locally without the pressure and cataract risks associated with steroids.
Monitoring With Imaging
Diagnosing papillary conjunctivitis traditionally relies on flipping the upper eyelid and looking at the tarsal conjunctiva with a slit lamp. This remains the standard approach. But newer imaging tools are adding precision, particularly for tracking treatment response over time. Anterior-segment optical coherence tomography (AS-OCT) can measure the height and width of individual papillae and track conjunctival thickness before and after treatment. In one study monitoring the response to tacrolimus therapy in VKC, researchers used AS-OCT’s built-in measurement tools to quantify papillae dimensions at baseline and again three months into treatment.
This kind of objective measurement is useful because clinical grading by slit lamp, while practical, is inherently subjective. Two clinicians looking at the same eyelid may disagree on whether the papillae are grade 2 or grade 3. Imaging gives a number that can be compared over time without relying on the observer’s judgment. For research purposes and for patients on long-term therapy where subtle changes matter, this technology is increasingly valuable.
Living With Papillary Conjunctivitis as a Contact Lens Wearer
If you wear contacts and develop papillary conjunctivitis, the prognosis is generally good as long as you are willing to make some changes. Switching to daily disposable lenses eliminates the protein buildup problem almost entirely, since you are throwing the lens away before deposits have time to accumulate. The dramatic difference in GPC incidence between infrequent and frequent lens replacement, from 36% down to under 5%, underscores how much the replacement schedule matters.
Some people find that rigid gas-permeable lenses, which resist protein deposits more effectively than soft lenses, are a good long-term option after a GPC episode. Others do well with hydrogen peroxide-based cleaning systems, which are more effective at removing protein deposits than multipurpose solutions. The key insight is that GPC in contact lens wearers is not an allergy to the lens material itself. It is a reaction to what accumulates on the lens and how that interacts with chronic mechanical irritation. Address those two factors and most people can return to comfortable lens wear.
The exception is people with significant underlying atopy. If you have eczema, asthma, or hay fever, your conjunctiva is already primed for an exaggerated immune response, and you may find that papillary problems recur more easily even with good lens hygiene. For this group, a lower threshold for switching to daily disposables or considering refractive surgery as an alternative to contacts is reasonable.
When Papillae Signal Something More Serious
For most contact lens wearers, papillary conjunctivitis is an annoyance that resolves with better lens habits and possibly a short course of drops. But papillae on the eyelid can also be a sign of VKC or AKC, conditions that require more aggressive and sustained management. The clinical context matters: a child in a warm climate with intense itching, thick ropy mucus discharge, and cobblestone papillae on the upper lid is a very different situation from an adult contact lens wearer with mild discomfort and moderate papillae.
VKC in particular carries real risks to vision if undertreated. The combination of giant papillae mechanically abrading the cornea, shield ulcers disrupting the corneal surface, and chronic inflammation potentially leading to scarring means that affected children often need years of careful management with immunomodulatory therapy. AKC, meanwhile, tends to be a chronic condition in adults with atopic dermatitis, and its lower-lid-predominant papillary pattern can help distinguish it from VKC’s upper-lid cobblestones. Both conditions benefit from the involvement of a specialist comfortable managing chronic ocular surface inflammation, rather than a simple prescription for antihistamine drops.